These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 3124503

  • 1. Multiple neuroendocrinological responses in borderline personality disorder patients.
    Kontaxakis V, Markianos M, Vaslamatzis G, Markidis M, Kanellos P, Stefanis C.
    Acta Psychiatr Scand; 1987 Nov; 76(5):593-7. PubMed ID: 3124503
    [Abstract] [Full Text] [Related]

  • 2. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD, Sullivan AC, Byrnes SM.
    Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
    [Abstract] [Full Text] [Related]

  • 3. Disturbances in the hypothalamo-pituitary-adrenal and other neuroendocrine axes in bulimia.
    Fichter MM, Pirke KM, Pöllinger J, Wolfram G, Brunner E.
    Biol Psychiatry; 1990 May 01; 27(9):1021-37. PubMed ID: 2110485
    [Abstract] [Full Text] [Related]

  • 4. Reduced prolactin response to fenfluramine challenge in personality disorder patients is not due to deficiency of pituitary lactotrophs.
    Coccaro EF, Klar H, Siever LJ.
    Biol Psychiatry; 1994 Sep 01; 36(5):344-6. PubMed ID: 7993962
    [No Abstract] [Full Text] [Related]

  • 5. Variability of hormonal responses to a series of neuroendocrine challenges in depressed patients.
    Winokur A, Amsterdam J, Caroff S, Snyder PJ, Brunswick D.
    Am J Psychiatry; 1982 Jan 01; 139(1):39-44. PubMed ID: 6798884
    [Abstract] [Full Text] [Related]

  • 6. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
    Rinne T, de Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den Brink W.
    Biol Psychiatry; 2002 Dec 01; 52(11):1102-12. PubMed ID: 12460693
    [Abstract] [Full Text] [Related]

  • 7. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
    Chen G.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug 01; 24(4):203-6, 251. PubMed ID: 1954790
    [Abstract] [Full Text] [Related]

  • 8. The TRH-induced TSH response in psychiatric patients: a possible neuroendocrine marker.
    Loosen PT.
    Psychoneuroendocrinology; 1985 Aug 01; 10(3):237-60. PubMed ID: 2865765
    [Abstract] [Full Text] [Related]

  • 9. The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients.
    Sternbach HA, Fleming J, Extein I, Pottash AL, Gold MS.
    Psychoneuroendocrinology; 1983 Aug 01; 8(4):459-62. PubMed ID: 6425891
    [Abstract] [Full Text] [Related]

  • 10. Amphetamine response in borderline patients.
    Schulz SC, Schulz PM, Dommisse C, Hamer RM, Blackard WG, Narasimhachari N, Friedel RO.
    Psychiatry Res; 1985 Jun 01; 15(2):97-108. PubMed ID: 3862151
    [Abstract] [Full Text] [Related]

  • 11. Psychoneuroendocrinology of depression.
    Brown GM.
    Psychiatr J Univ Ott; 1989 Jun 01; 14(2):344-8; discussion 349-51. PubMed ID: 2503840
    [Abstract] [Full Text] [Related]

  • 12. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
    Tajima-Pozo K, Montes-Montero A, Güemes I, González-Vives S, Díaz-Marsá M, Carrasco JL.
    Endocrinol Nutr; 2013 Jun 01; 60(7):396-403. PubMed ID: 23623464
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone suppression and multiple hormonal responses (TSH, prolactin and growth hormone) to TRH in some psychiatric disorders.
    Banki CM, Vojnik M, Arato M, Papp Z, Kovacs Z.
    Eur Arch Psychiatry Neurol Sci; 1985 Jun 01; 235(1):32-7. PubMed ID: 3930250
    [Abstract] [Full Text] [Related]

  • 14. [Value and limits of conducting several neuro-endocrine tests in the diagnosis of depressive states].
    Schmitt L, Granier F, Girard M, Zarouk B, Escande M.
    Ann Med Psychol (Paris); 1985 Feb 01; 143(2):166-74. PubMed ID: 3929664
    [No Abstract] [Full Text] [Related]

  • 15. Associations among dexamethasone non-suppression and TRH-induced hormonal responses: increased specificity for melancholia?
    Banki CM, Arato M, Papp Z, Rihmer Z, Kovacs Z.
    Psychoneuroendocrinology; 1986 Feb 01; 11(2):205-11. PubMed ID: 3092267
    [Abstract] [Full Text] [Related]

  • 16. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E, Kartalci S, Tutus A, Turan T, Sofuoglu S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar 01; 28(2):303-9. PubMed ID: 14751427
    [Abstract] [Full Text] [Related]

  • 17. TRH tests with analyses of TSH, prolactin, and GH responses in subtypes of patients with major depressive disorders.
    Agren H, Wide L.
    Acta Psychiatr Scand; 1986 May 01; 73(5):549-58. PubMed ID: 3092581
    [Abstract] [Full Text] [Related]

  • 18. [The endocrine abnormalities of depressive patients].
    Yang Q.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Apr 01; 25(2):69-73, 125. PubMed ID: 1499410
    [Abstract] [Full Text] [Related]

  • 19. Borderline and cluster C personality disorders manifest distinct physiological responses to psychosocial stress.
    Aleknaviciute J, Tulen JH, Kamperman AM, de Rijke YB, Kooiman CG, Kushner SA.
    Psychoneuroendocrinology; 2016 Oct 01; 72():131-8. PubMed ID: 27413994
    [Abstract] [Full Text] [Related]

  • 20. Associations of childhood trauma with hypothalamic-pituitary-adrenal function in borderline personality disorder and major depression.
    Carvalho Fernando S, Beblo T, Schlosser N, Terfehr K, Otte C, Löwe B, Wolf OT, Spitzer C, Driessen M, Wingenfeld K.
    Psychoneuroendocrinology; 2012 Oct 01; 37(10):1659-68. PubMed ID: 22444624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.